Pfizer Inc. PFE
Loading live quote…
$26.17
+0.57
(+2.23%)
Price Chart
About Pfizer, Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic…
Recent Quarters
| Quarter | Revenue | Net Income | EPS (dil.) | Gross Margin |
|---|---|---|---|---|
| 2026 Q1 | — | $2.69B | 0.47 | 75.5% |
| 2025 Q4 | — | $-1,648,000,000 | -0.29 | 70.0% |
| 2025 Q3 | — | $3.54B | 0.62 | 75.0% |
| 2025 Q2 | — | $2.91B | 0.51 | 74.2% |
PFE — Latest Coverage
